Antianaerobic Activity of Sulopenem Compared to Six Other Agents

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

Agar dilution MIC methodology was used to compare the activity of sulopenem with those of amoxicillin/clavulanate, ampicillin/sulbactam, piperacillin-tazobactam, imipenem, clindamycin, and metronidazole against 431 anaerobes. Overall, MIC(50)/(90) values were as follows: sulopenem, 0.25/1.0 microg/ml; amoxicillin/clavulanate, 0.5/2.0 microg/ml; ampicillin/sulbactam, 0.5/4.0 microg/ml; piperacillin/tazobactam, 0.25/8.0 microg/ml; imipenem, 0.06/1.0 microg/ml; clindamycin, 0.25/16.0 microg/ml; and metronidazole, 1.0/4.0 microg/ml.

Knowledge Graph

Similar Paper

Antianaerobic Activity of Sulopenem Compared to Six Other Agents
Antimicrobial Agents and Chemotherapy 2009.0
Comparative Antipneumococcal Activities of Sulopenem and Other Drugs
Antimicrobial Agents and Chemotherapy 2009.0
Comparative Antianaerobic Activities of Doripenem Determined by MIC and Time-Kill Analysis
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activities of Doripenem and Six Comparator Drugs against 423 Aerobic and Anaerobic Bacterial Isolates from Infected Diabetic Foot Wounds
Antimicrobial Agents and Chemotherapy 2008.0
Antimicrobial Susceptibility Patterns for Recent Clinical Isolates of Anaerobic Bacteria in South Korea
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activity of Tomopenem (CS-023/RO4908463) against Anaerobic Bacteria
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activities of Doripenem, a New Broad-Spectrum Carbapenem, against Recently Collected Clinical Anaerobic Isolates, with Emphasis on the Bacteroides fragilis Group
Antimicrobial Agents and Chemotherapy 2008.0
Susceptibilities of 23 Desulfovibrio Isolates from Humans
Antimicrobial Agents and Chemotherapy 2009.0
Study of the In Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel Flora
Antimicrobial Agents and Chemotherapy 2009.0